The effect size of the differences in VEGF concentrations between SLE patients and controls was not associated with disease duration, use of glucocorticoids and immunosuppressors, biological matrix assessed, or analytical method used. The gene discussed is VEGFA; the disease is systemic lupus erythematosus.